Cargando…

Potential role between inflammatory cytokines and Tie-2 receptor levels and clinical symptoms in patients with first-episode schizophrenia

BACKGROUND: Schizophrenia (SCZ) is associated with chronic low-grade inflammation, which may be involved in the underlying pathological mechanism of the disease and may influence patient prognosis. We evaluated the differences in serum cytokine and Tie-2 receptor levels between patients with first-e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Fanfan, Meng, Xiaojing, Cheng, Xialong, Pei, Wenzhi, Chen, Yuanyuan, Chen, Long, Zheng, Mingming, Shi, Li, Zhu, Cuizhen, Zhang, Xulai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367336/ https://www.ncbi.nlm.nih.gov/pubmed/37491201 http://dx.doi.org/10.1186/s12888-023-04913-7

Ejemplares similares

Correlation between elevated serum interleukin-1β, interleukin-16 levels and psychiatric symptoms in patients with schizophrenia at different stages
por: Cheng, Xialong, et al.
Publicado: (2023)

Childhood maltreatment increases the suicidal risk in Chinese schizophrenia patients
por: Cheng, Peng, et al.
Publicado: (2022)

Network Association of Biochemical and Inflammatory Abnormalities With Psychiatric Symptoms in First-Episode Schizophrenia Patients
por: Yan, Junwei, et al.
Publicado: (2022)

Intricate role of intestinal microbe and metabolite in schizophrenia
por: Shi, Li, et al.
Publicado: (2023)

Association Between Abundance of Haemophilus in the Gut Microbiota and Negative Symptoms of Schizophrenia
por: Zhu, Cuizhen, et al.
Publicado: (2021)

Cytokine alterations in first-episode schizophrenia and bipolar disorder: relationships to brain structure and symptoms
por: Lesh, Tyler A., et al.
Publicado: (2018)

Association between Peripheral Inflammatory Cytokines and Cognitive Function in Patients with First-Episode Schizophrenia
por: Baek, Seon-Hwa, et al.
Publicado: (2022)

Potential Role of Pain Catastrophic Thinking in Comorbidity Patients of Depression and Chronic Pain
por: Chen, Yuanyuan, et al.
Publicado: (2022)

Gender Difference in the Prodromal Symptoms of First-episode Schizophrenia
por: Choi, Jung-Seok, et al.
Publicado: (2009)

Symptoms at Onset in First Episode Schizophrenia: Caregivers Perspectives
por: Tharoor, Hema, et al.
Publicado: (2015)

Prediction of violence in male schizophrenia using sMRI, based on machine learning algorithms
por: Yu, Tao, et al.
Publicado: (2022)

Cognitive-perceptual deficits and symptom correlates in first-episode schizophrenia
por: Olivier, Riaan M., et al.
Publicado: (2017)

Effects of Modified Electroconvulsive Therapy on Serum Cortisol, Nesfatin-1, and Pro-inflammatory Cytokine Levels in Elderly Patients With Treatment-Resistant Depression
por: Dai, Biao, et al.
Publicado: (2022)

Aberrant effective connectivity is associated with positive symptoms in first-episode schizophrenia
por: Dietz, Martin J., et al.
Publicado: (2020)

Associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia
por: Zhang, Yan, et al.
Publicado: (2021)

Impact of Negative Symptoms on Functioning and Quality of Life in First Psychotic Episodes of Schizophrenia
por: García-Fernández, Lorena, et al.
Publicado: (2022)

Cognitive dysfunction in first-episode schizophrenia and its correlation with negative symptoms and insight
por: Bhat, Pookala Shivaram, et al.
Publicado: (2021)

PM475. White matter abnormalities and their associations with clinical symptoms in first episode and drug-naïve patients with schizophrenia
por: Zhang, Xiang-Yang, et al.
Publicado: (2016)

Baseline BMI is associated with clinical symptom improvements in first-episode schizophrenia: a longitudinal study
por: Chen, Xiaofang, et al.
Publicado: (2023)

Treatment Response in First-episode Schizophrenia
por: Schennach, Rebecca, et al.
Publicado: (2012)

The neurobiology and treatment of first-episode schizophrenia
por: Kahn, R S, et al.
Publicado: (2015)

Dysexecutive Behavior in First-Episode Schizophrenia
por: Orellana, Gricel, et al.
Publicado: (2022)

Impaired Emotional Self-Referential Processing in First-Episode Schizophrenia
por: Zhao, Yanli, et al.
Publicado: (2021)

Relationship between negative symptoms and neurocognitive functions in adolescent and adult patients with first-episode schizophrenia
por: Huang, Manli, et al.
Publicado: (2016)

Inflammatory markers of symptomatic remission at 6 months in patients with first-episode schizophrenia
por: Kim, Honey, et al.
Publicado: (2023)

Sex difference in association of symptoms and white matter deficits in first-episode and drug-naive schizophrenia
por: Lang, Xiao-E, et al.
Publicado: (2018)

Affective prosody and facial emotion recognition in first-episode schizophrenia: Associations with functioning & symptoms
por: Bonfils, Kelsey A., et al.
Publicado: (2019)

The Relationship between Cognitive Functions and Psychopathological Symptoms in First Episode Psychosis and Chronic Schizophrenia
por: Rek-Owodziń, Katarzyna, et al.
Publicado: (2022)

Negative symptoms in first episode schizophrenia: Results from the “parma early psychosis” program
por: Pelizza, L., et al.
Publicado: (2021)

The contribution of the cingulate cortex: treating depressive symptoms in first-episode drug naïve schizophrenia
por: Shen, Haoran, et al.
Publicado: (2023)

Obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidone
por: Gao, Zhiyong, et al.
Publicado: (2023)

Impaired dynamic functional brain properties and their relationship to symptoms in never treated first-episode patients with schizophrenia
por: You, Wanfang, et al.
Publicado: (2022)

Structural abnormalities of cingulate cortex in patients with first‐episode drug‐naïve schizophrenia comorbid with depressive symptoms
por: Wei, Gao‐Xia, et al.
Publicado: (2020)

Cytokine alterations in CSF and serum samples of patients with a first episode of schizophrenia: results and methodological considerations
por: Singh, Deepti, et al.
Publicado: (2023)

Abnormal Brain Network Interaction Associated With Positive Symptoms in Drug-Naive Patients With First-Episode Schizophrenia
por: Yuan, Liu, et al.
Publicado: (2022)

Decreased bilateral thalamic gray matter volume in first-episode schizophrenia with prominent hallucinatory symptoms: A volumetric MRI study
por: Huang, Peng, et al.
Publicado: (2015)

Disease-relevant autoantibodies in first episode schizophrenia
por: Zandi, Michael S., et al.
Publicado: (2010)

Executive attention impairment in first-episode schizophrenia
por: Orellana, Gricel, et al.
Publicado: (2012)

Sleep quality in first-episode schizophrenia patients
por: Abdellatif, M., et al.
Publicado: (2023)

PM505. Impaired glucose tolerance, symptoms and cognitive deficits in first-episode drug-naïve patients with schizophrenia
por: Zhang, Xiang-Yang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_118q8n047stb106l8bidsftc62